Inkhabar webdesk

(Reuters) -Halliburton beat Wall Street estimates for third quarter profit on Tuesday, helped by steady demand for its oilfield equipment and services in North America. The company reported an adjusted profit of 58 cents per share for the quarter ended September 30, compared with analysts' estimate of 50 cents, according to data compiled by LSEG. (Reporting by Tanay Dhumal in Bengaluru; Editing by Tasim Zahid)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

-Industrial giant 3M raised annual profit forecast on Tuesday, driven by cost-cutting measures and a strategic shift toward high-margin products, sending its shares up as much as 2.6% in premarket trading. Under CEO Bill Brown, 3M has steered toward product innovation and pivoted away from its earlier emphasis on managing legal risks and cutting supply-chain costs. The conglomerate forecasts 2025 operating margin to expand 180 to 200 basis points, compared with its previous projection of a rise of 150 to 200 basis points. It expects 2025 adjusted profit to be between $7.95 and $8.05 per share, compared with its previous forecast of $7.75 to $8 per share. (Reporting by Aishwarya Jain in Bengaluru; Editing by Shilpi Majumdar)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

(Reuters) -GE Aerospace raised its 2025 profit forecast on Tuesday, projecting a strong finish to the year on robust demand for aftermarket maintenance services due to a shortage of new jets. Jet deliveries from Boeing and Airbus have lagged demand from airlines, forcing carriers to spend more on the maintenance of older jets. That has benefited GE Aerospace, which sells engines at relatively low upfront prices and earns most of its profit from high-margin, long-term contracts for parts and maintenance over an engine's life cycle. The company expects annual profit per share in the range of $6.00 to $6.20, compared with its prior expectations of $5.60 to $5.80. Third-quarter operating profit at its commercial engines and services unit rose 35% to $2.44 billion, while revenue climbed 27% to $8.88 billion from a year ago. The segment derives more than 70% of its sales from parts and services. With aerospace supply chains improving, engine makers are expected to ramp up deliveries of new engines. GE holds a strong position in the jet engine market through CFM International, its long-standing joint venture with France's Safran SA. Earlier this month, Safran CEO Olivier Andries said the company was "on a good path" to catch up on delayed engine deliveries to Airbus by the end of October. GE customer Boeing also recently received regulatory approval to increase production of its bestseller 737 MAX jets, which are exclusively powered by CFM's LEAP-1B engines. GE Aerospace's adjusted profit per share for the quarter through September jumped 44% to $1.66. For the quarter ended Sept. 30, its adjusted revenue rose 26% to $11.31 billion. (Reporting by Shivansh Tiwary in Bengaluru; Editing by Arun Koyyur)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

(Reuters) -U.S. stock index futures edged lower on Tuesday, following Wall Street's strong rally in the previous session, as investors prepared for a deluge of quarterly results from major corporations. All the three major indexes had closed with gains of more than 1% on Monday, marking their best day in more than a week, as upbeat earnings expectations and easing concerns over regional bank credit quality boosted risk appetite. Markets are now expected to face a fresh litmus test with heavyweights, including Tesla, IBM, Procter & Gamble, Coca-Cola, Intel and Ford, set to report this week. Shares of General Motors, set to report its financials before market open, slipped 2.1% in premarket trading. 3M was up 1.1% ahead of its results. Netflix, scheduled to report after markets close, also edged higher. At 05:20 a.m., Dow E-minis were down 83 points, or 0.18%, S&P 500 E-minis were down 7.25 points, or 0.11%, and Nasdaq 100 E-minis were down 24.25 points, or 0.1%. Futures tied to the small-cap Russell 2000 also edged lower, after the index jumped nearly 2% in the previous session. Mega-cap stocks were a mixed bag. Apple eased 0.2% after hitting a record high on Monday. Meta gained 0.3%, while Alphabet slipped 0.4%. Regional bank earnings are also in focus to get a closer read on the sector's health after fears of systemic stress sparked a selloff last week. But with valuations stretched and markets hovering near record highs, analysts say that earnings beats alone may not be enough to sustain the rally. Investors will be watching margin resilience and forward guidance, especially amid persistent trade tensions and lingering inflation concerns. Uncertainty surrounding the U.S. government shutdown is also dampening sentiment as delays in key economic data releases obscure market visibility. However, White House economic adviser Kevin Hassett said on Monday the shutdown was likely to end this week. U.S. President Donald Trump also struck a hopeful tone on trade, saying he expects to reach a "fair deal" with Chinese President Xi Jinping, while downplaying tensions over Taiwan. Investors are now eyeing Trump's upcoming meeting with Xi on the sidelines of next week's economic summit in South Korea. Among other stocks, Fluor jumped 6.8% in premarket trading, after reports said activist investor Starboard Value has taken a nearly 5% stake in the construction firm. (Reporting by Pranav Kashyap in Bengaluru; Editing by Shilpi Majumdar)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

DUBAI (Reuters) -Goldman Sachs is setting up a private wealth management team in Saudi Arabia, it said on Tuesday, as it boosts its offer in the Middle East to serve a growing number of high net worth individuals in the region. In May last year, the U.S. bank obtained a licence to set up its regional headquarters in Riyadh, where it has had an office since 2008, and the wealth management team will extend the office's capabilities, Goldman Sachs said in a statement. The bank is among global firms expanding their footprint in the kingdom as Saudi Arabia seeks to reduce its dependence on oil revenue by investing in sectors such as financial services. "Saudi Arabia has an exceptionally dynamic economy and a highly sophisticated investor base," Rob Mullane, Goldman Sachs' co-head of private wealth management for the EMEA region, said in a statement. The bank plans to open up "local and global investment opportunities," for regional clients, he said. The bank said it is hiring staff in the region. (Reporting by Federico Maccioni, editing by Susan Fenton)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

ZURICH (Reuters) -Swiss exports to the United States rebounded sharply in September, with pharmaceutical companies ramping up their shipments ahead of the introduction of U.S. tariffs, government data showed on Tuesday. Total nominal Swiss exports to the United States leapt by nearly 43% last month in seasonally adjusted terms compared to the previous month, the figures showed. Overall, Swiss exports were up 3.4% in September. U.S. President Donald Trump imposed 39% tariffs on Switzerland in August, triggering a sharp drop in Swiss exports to the United States that month. Pharmaceutical companies were, however, exempted from the initial U.S. duties. In late September, Trump said he would from October 1 impose a 100% tariff on imports of branded or patented pharmaceutical products, unless a pharmaceutical company is building a manufacturing plant in the United States. Major Swiss pharma companies such as Roche and Novartis indicated they did not expect those U.S. measures to apply to them because of their expansion plans in the country. Adjusted for seasonal swings, total Swiss exports of chemical and pharmaceutical products jumped in September by 5.1% in nominal terms compared to the previous month. That category accounts for more than half of all Swiss goods exports. (Writing by Dave Graham, editing by John Revill)

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)